Novel MCH receptor antagonists

Details for Australian Patent Application No. 2005316313 (hide)

Owner Eli Lilly and Company

Inventors Greenen, Peter Michael; Gardinier, Kevin Matthew; Cordier, Frederic Laurent; Wakefield, Brian David; Beck, James Peter; Savin, Kenneth Allen; Dominguez-Manzanares, Esteban

Agent Spruson & Ferguson

Pub. Number AU-B-2005316313

PCT Pub. Number WO2006/066173

Priority 60/637,116 17.12.04 US

Filing date 16 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 29 September 2011

International Classifications

C07D 263/58 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/066173 Priority application(s): WO2006/066173

29 September 2011 Application Accepted

  Published as AU-B-2005316313

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316314-Thiazolopyridinone derivates as MCH receptor antagonists

2005316312-Aminopyrimidine compounds and methods of use